Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD

Y.-S. Ding, M. Naganawa, Jean-Dominique Gallezot, Nabeel Nabulsi, S.-F. Lin, J. Ropchan, David Weinzimmer, Timothy J. McCarthy, Richard E. Carson, Yiyun Huang, Marc Laruelle. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD. NeuroImage, 86:164-171, 2014. [doi]

References

No references recorded for this publication.

Cited by

No citations of this publication recorded.